Search by Drug Name or NDC

NDC 13107-0015-01 GLYCOPYRROLATE 2 mg/1 Details

GLYCOPYRROLATE 2 mg/1

GLYCOPYRROLATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurolife Pharma LLC. The primary component is GLYCOPYRROLATE.

MedlinePlus Drug Summary

Glycopyrrolate is used in combination with other medications to treat ulcers in adults and children 12 years of age and older. Glycopyrrolate (Cuvposa) is used to reduce saliva and drooling in children between 3 and16 years of age that have certain medical conditions that cause drooling. Glycopyrrolate is in a class of medications called anticholinergics. It decreases stomach acid and saliva production by blocking the activity of a certain natural substance in the body.

Related Packages: 13107-0015-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Glycopyrrolate

Product Information

NDC	13107-0015
Product ID	13107-015_ceb690df-82b4-4a15-8d74-3571d5cf16a5
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	GLYCOPYRROLATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	GLYCOPYRROLATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	GLYCOPYRROLATE
Labeler Name	Aurolife Pharma LLC
Pharmaceutical Class	Anticholinergic [EPC], Cholinergic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA202675
Listing Certified Through	2024-12-31

Package

NDC 13107-0015-01 (13107001501)

Pricing Information	N/A
NDC Package Code	13107-015-01
Billing NDC	13107001501
Package	100 TABLET in 1 BOTTLE (13107-015-01)
Marketing Start Date	2018-10-30
NDC Exclude Flag	N